32587124|t|Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from beta-amyloid neurotoxicity through synergistically enhanced SIRT1 expression.
32587124|a|Alzheimer's disease (AD) is a multi-faceted neurodegenerative disease. Thus, current therapeutic strategies require multitarget-drug combinations to treat or prevent the disease. At the present time, single drugs have proven to be inadequate in terms of addressing the multifactorial pathology of AD, and multitarget-directed drug design has not been successful. Based on these points of views, it is judged that combinatorial drug therapies that target several pathogenic factors may offer more attractive therapeutic options. Thus, we explored that the combination therapy with lower doses of cilostazol and aripiprazole with add-on donepezil (CAD) might have potential in the pathogenesis of AD. In the present study, we found the superior efficacies of donepezil add-on with combinatorial mixture of cilostazol plus aripiprazole in modulation of expression of AD-relevant genes: Abeta accumulation, GSK-3beta, P300, acetylated tau, phosphorylated-tau levels, and activation of alpha-secretase/ADAM 10 through SIRT1 activation in the N2a Swe cells expressing human APP Swedish mutation (N2a Swe cells). We also assessed that CAD synergistically raised acetylcholine release and choline acetyltransferase (CHAT) expression that were declined by increased beta-amyloid level in the activated N2a Swe cells. Consequently, CAD treatment synergistically increased neurite elongation and improved cell viability through activations of PI3K, BDNF, beta-catenin and a7-nicotinic cholinergic receptors in neuronal cells in the presence of Abeta1-42. This work endorses the possibility for efficient treatment of AD by supporting the synergistic therapeutic potential of donepezil add-on therapy in combination with lower doses of cilostazol and aripiprazole.
32587124	25	35	cilostazol	Chemical	MESH:D000077407
32587124	37	49	aripiprazole	Chemical	MESH:D000068180
32587124	55	64	donepezil	Chemical	MESH:D000077265
32587124	107	120	neurotoxicity	Disease	MESH:D020258
32587124	154	159	SIRT1	Gene	93759
32587124	172	191	Alzheimer's disease	Disease	MESH:D000544
32587124	193	195	AD	Disease	MESH:D000544
32587124	216	241	neurodegenerative disease	Disease	MESH:D019636
32587124	469	471	AD	Disease	MESH:D000544
32587124	767	777	cilostazol	Chemical	MESH:D000077407
32587124	782	794	aripiprazole	Chemical	MESH:D000068180
32587124	807	816	donepezil	Chemical	MESH:D000077265
32587124	818	821	CAD	Chemical	-
32587124	867	869	AD	Disease	MESH:D000544
32587124	929	938	donepezil	Chemical	MESH:D000077265
32587124	976	986	cilostazol	Chemical	MESH:D000077407
32587124	992	1004	aripiprazole	Chemical	MESH:D000068180
32587124	1036	1038	AD	Disease	MESH:D000544
32587124	1055	1060	Abeta	Gene	351
32587124	1075	1084	GSK-3beta	Gene	56637
32587124	1086	1090	P300	Gene	2033
32587124	1103	1106	tau	Gene	4137
32587124	1123	1126	tau	Gene	4137
32587124	1169	1176	ADAM 10	Gene	102
32587124	1185	1190	SIRT1	Gene	93759
32587124	1209	1216	N2a Swe	CellLine	CVCL:D650
32587124	1234	1239	human	Species	9606
32587124	1262	1269	N2a Swe	CellLine	CVCL:D650
32587124	1300	1303	CAD	Chemical	-
32587124	1327	1340	acetylcholine	Chemical	MESH:D000109
32587124	1353	1378	choline acetyltransferase	Gene	12647
32587124	1380	1384	CHAT	Gene	12647
32587124	1465	1472	N2a Swe	CellLine	CVCL:D650
32587124	1494	1497	CAD	Chemical	-
32587124	1610	1614	BDNF	Gene	12064
32587124	1616	1628	beta-catenin	Gene	12387
32587124	1778	1780	AD	Disease	MESH:D000544
32587124	1836	1845	donepezil	Chemical	MESH:D000077265
32587124	1896	1906	cilostazol	Chemical	MESH:D000077407
32587124	1911	1923	aripiprazole	Chemical	MESH:D000068180
32587124	Cotreatment	MESH:D000077265	MESH:D000077407
32587124	Negative_Correlation	MESH:D000077265	351
32587124	Positive_Correlation	MESH:D000077407	93759
32587124	Association	MESH:D000544	351
32587124	Positive_Correlation	MESH:D000068180	102
32587124	Association	MESH:D000544	102
32587124	Association	MESH:D000544	2033
32587124	Negative_Correlation	MESH:D000077407	MESH:D000544
32587124	Association	MESH:D000544	56637
32587124	Negative_Correlation	MESH:D000077407	MESH:D020258
32587124	Positive_Correlation	MESH:D000077407	102
32587124	Negative_Correlation	MESH:D000068180	MESH:D020258
32587124	Positive_Correlation	MESH:D000077265	102
32587124	Negative_Correlation	MESH:D000068180	MESH:D000544
32587124	Negative_Correlation	MESH:D000077407	4137
32587124	Negative_Correlation	MESH:D000068180	4137
32587124	Negative_Correlation	MESH:D000077265	MESH:D000544
32587124	Positive_Correlation	MESH:D000077265	93759
32587124	Association	MESH:D000544	93759
32587124	Negative_Correlation	MESH:D000077265	4137
32587124	Negative_Correlation	MESH:D000077265	MESH:D020258
32587124	Positive_Correlation	MESH:D000077265	2033
32587124	Cotreatment	MESH:D000068180	MESH:D000077265
32587124	Positive_Correlation	MESH:D000068180	93759
32587124	Positive_Correlation	102	93759
32587124	Negative_Correlation	MESH:D000068180	351
32587124	Negative_Correlation	MESH:D000068180	56637
32587124	Negative_Correlation	MESH:D000077265	56637
32587124	Association	MESH:D000544	4137
32587124	Positive_Correlation	MESH:D000068180	2033

